P777: EFFICACY AND SAFETY OF ROMIPLOSTIM COMBINED WITH CYCLOSPORINE A AS A FIRST-LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL.

• Shigeru Chiba,
• Jong Wook Lee,
• Jun Ho Jang,
• Sung-Soo Yoon,
• Gaku Oshikawa,
• Kensuke Usuki,
• Yeung-Chul Mun,
• Toshiro Kawakita,
• Kazunori Imada,
• June-Won Cheong,
• Masayoshi Noshiro,
• Akira Matsuda,
• Keiya Ozawa,
• Kinuko Mitani,
• Yoshinobu Kanda,
• Shinji Nakao

Affiliations

Shigeru Chiba

1 University of Tsukuba, Department of Hematology, Tsukuba, Japan

Jong Wook Lee

2 Seoul St. Mary’s Hospital, The Catholic University of Korea, Division of Hematology, Seoul, Korea, Rep. of South

Jun Ho Jang

3 Sungkyunkwan University Samsung Medical Center, Department of Hematology, Seoul, Korea, Rep. of South

Sung-Soo Yoon

4 Seoul National University Hospital, Department of Internal Medicine, Seoul, Korea, Rep. of South

Gaku Oshikawa

5 Japan Red Cross Musashino Hospital Tokyo, Department of Hematology, Tokyo, Japan

Kensuke Usuki

6 NTT Medical Center Tokyo, Department of Hematology, Tokyo, Japan

Yeung-Chul Mun

7 Ewha Womans’ University College of Medicine, Department of Internal Medicine, Seoul, Korea, Rep. of South

Toshiro Kawakita

8 National Hospital Organization Kumamoto Medical Center, Department of Hematology, Kumamoto, Japan

Kazunori Imada

9 Japanese Red Cross Osaka Hospital, Department of Hematology, Osaka, Japan

June-Won Cheong

10 Severance Hospital, Yonsei University College of Medicine, Division of Hematology, Department of Internal Medicine, Seoul, Korea, Rep. of South

Masayoshi Noshiro

11 Kyowa Kirin Co., Ltd., Tokyo, Japan

Akira Matsuda

12 Saitama Medical University International Medical Center, Department of Hemato-Oncology, Saitama, Japan

Keiya Ozawa

13 Jichi Medical University, Division of Hematology, Department of Medicine, Tochigi, Japan

Kinuko Mitani

14 Dokkyo Medical University, Department of Hematology and Oncology, Tochigi, Japan

Yoshinobu Kanda

13 Jichi Medical University, Division of Hematology, Department of Medicine, Tochigi, Japan

Shinji Nakao

15 Kanazawa University, Department of Hematology, Kanazawa, Japan